Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early-Viral-Dynamics Study (EVD)
NCT00710216Phase 4Withdrawn
- Sponsor
- Ulm University
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Ulm University. Status: withdrawn.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00710216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710216.